A condition that compels people to move their legs could indicate they have a greater chance of developing Parkinson's ...

An experimental Parkinson’s disease drug on its way to AbbVie as part of an $8.7 billion acquisition has met the goals of a pivotal study, setting up the pharmaceutical giant with a drug prospect that ...

Jan. 14 -- WEDNESDAY, Jan. 13 (HealthDay News) -- Reduced dosages of dopamine agonists, drugs routinely used to treat Parkinson's disease, can cause symptoms similar to those experienced by addicts in ...

The 2025 AASM guidelines recommend iron supplementation as the first-line treatment for RLS when ferritin levels are below 75 ng/mL. Dopamine agonists like ropinirole can reduce RLS symptoms but carry ...

Dopamine, a key neurotransmitter in the brain, plays a vital role in regulating movement, emotion, and cognition. It is central to the pathology of several major neurological and psychiatric ...

New research backs up previous findings about a connection between the two, though some have urged caution in interpreting ...

Nat Clin Pract Endocrinol Metab. 2006;2(6):298-299. Clearly, dopamine agonists should not be withdrawn too early, and certainly not before completion of 12 months' treatment. Until more is known about ...

Women who were prescribed medication to deal with a neurological disorder that impacts one in 10 Americans have said that the ...